In contrast to MYBPC3, the pathogenic involvement of skeletal MyBP-C mutations was only recently revealed when MYBPC1 mutations were found in patients with the congenital muscle diseases DA and LCCS. The gene discussed is MYBPC3; the disease is lethal congenital contracture syndrome.